Pharmazeutische Zusammensetzung eines Schwachsauren Arzneimittels und Verfahren zur Verabreichung
EP4751773
3. Juni 2026
Anmelder: Pharmosa Biopharm Inc. 🇹🇼
Details
- Veröffentlichungs-Nr.
- EP4751773
- Anmeldetag
- 13. Mai 2020
- Veröffentlichung
- 3. Juni 2026
- Rechtsraum
- EP
- IPC
- A61P11/00
Abstract
The present invention relates to a pharmaceutical composition containing liposomes, said liposome comprise an external lipid bilayer; and an internal aqueous medium including a weak acid drug with a half-life of less than 2 hours. Also provided is the use of the pharmaceutical composition disclosed herein to treat pulmonary hypertension with reduced dosing frequency.
Anmelder
- Firma
- Pharmosa Biopharm Inc.
- Land
- 🇹🇼 Taiwan